82 FR 57286 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 82, Issue 231 (December 4, 2017)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 82, Issue 231 (December 4, 2017)
| Page Range | 57286-57288 | |
| FR Document | 2017-26016 |
[Federal Register Volume 82, Number 231 (Monday, December 4, 2017)] [Notices] [Pages 57286-57288] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-26016] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). [[Page 57287]] SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 7920). The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated January 23, 2017 (82 FR 7920), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW, Edmonton, AB Canada T6B 2N7, 780-784- 1190 (Formerly: Gamma-Dynacare Medical Laboratories) HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 844-486-9226 Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823 (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.) Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783 (Formerly: Forensic Toxicology Laboratory Baptist Medical Center) Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 66215-2802, 800-445-6917 DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890 Dynacare,* 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630 (Formerly: Gamma-Dynacare Medical Laboratories) ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609 Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387 Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986 (Formerly: Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984 (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339 (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center) LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845 (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.) MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244 Legacy Laboratory Services--MetroLab, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295 Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, Testing for Veterans Affairs (VA) Employees Only National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515 One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774 (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory) Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology Laboratory) Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7 Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840 Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216 (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 91304, 818-737-6370 (Formerly: SmithKline Beecham Clinical Laboratories) Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159 STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800-442-0438 U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for Department of Defense (DoD) Employees Only * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with [[Page 57288]] the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on January 23, 2017 (82 FR 7920). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Brian Makela, Chemist. [FR Doc. 2017-26016 Filed 12-1-17; 8:45 am] BILLING CODE 4160-20-P
![57286 Federal Register / Vol. 82, No. 231 / Monday, December 4, 2017 / Notices
(Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND government-issued photo ID, driver’s license,
Program Nos. 93.847, Diabetes, HUMAN SERVICES or passport) and to state the purpose of their
Endocrinology and Metabolic Research; visit.
93.848, Digestive Diseases and Nutrition National Institutes of Health Information is also available on the
Research; 93.849, Kidney Diseases, Urology Institute’s/Center’s home page: https://
National Institute of Nursing Research; www.National Advisory Council for Nursing
and Hematology Research, National Institutes
Notice of Meeting Research|National Institute of Nursing
of Health, HHS)
Research, where an agenda and any
Dated: November 28, 2017. Pursuant to section 10(d) of the additional information for the meeting will
David Clary, Federal Advisory Committee Act, as be posted when available.
amended, notice is hereby given of a (Catalogue of Federal Domestic Assistance
Program Analyst, Office of Federal Advisory
meeting of the National Advisory Program Nos. 93.361, Nursing Research,
Committee Policy.
Council for Nursing Research. National Institutes of Health, HHS)
[FR Doc. 2017–25984 Filed 12–1–17; 8:45 am]
The meeting will be open to the Dated: November 28, 2017.
BILLING CODE 4140–01–P
public as indicated below, with Sylvia L. Neal,
attendance limited to space available. Program Analyst, Office of Federal Advisory
Individuals who plan to attend and Committee Policy.
DEPARTMENT OF HEALTH AND
need special assistance, such as sign [FR Doc. 2017–25986 Filed 12–1–17; 8:45 am]
HUMAN SERVICES language interpretation or other BILLING CODE 4140–01–P
reasonable accommodations, should
National Institutes of Health
notify the Contact Person listed below
National Institute on Aging; Notice of in advance of the meeting. DEPARTMENT OF HEALTH AND
Closed Meeting The meeting will be closed to the HUMAN SERVICES
public in accordance with the
Pursuant to section 10(d) of the provisions set forth in sections Substance Abuse and Mental Health
Federal Advisory Committee Act, as 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Services Administration
amended, notice is hereby given of the as amended. The grant applications and
the discussions could disclose Current List of HHS-Certified
following meeting.
confidential trade secrets or commercial Laboratories and Instrumented Initial
The meetings will be closed to the property such as patentable material, Testing Facilities Which Meet Minimum
public in accordance with the and personal information concerning Standards To Engage in Urine Drug
provisions set forth in sections individuals associated with the grant Testing for Federal Agencies
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which
as amended. The grant applications and would constitute a clearly unwarranted AGENCY: Substance Abuse and Mental
the discussions could disclose invasion of personal privacy. Health Services Administration, HHS.
confidential trade secrets or commercial ACTION: Notice.
Name of Committee: National Advisory
property such as patentable material, Council for Nursing Research January 23–24,
and personal information concerning 2018.
SUMMARY: The Department of Health and
individuals associated with the grant Open: January 23, 2018, 12:30 p.m. to 4:05 Human Services (HHS) notifies federal
applications, the disclosure of which p.m. agencies of the laboratories and
would constitute a clearly unwarranted Agenda: Discussion of Program Policies Instrumented Initial Testing Facilities
invasion of personal privacy. and Issues. (IITF) currently certified to meet the
Place: National Institutes of Health standards of the Mandatory Guidelines
Name of Committee: National Institute on Building 31, 6th Floor, C Wing, Room 6, 31 for Federal Workplace Drug Testing
Aging Special Emphasis Panel; Alzheimer’s Center Drive, Bethesda, MD 20892. Programs (Mandatory Guidelines).
Disease Drug Development. Closed: January 24, 2018, 9:00 a.m. to 1:00
p.m. A notice listing all currently HHS-
Date: December 13, 2017. certified laboratories and IITFs is
Agenda: To review and evaluate grant
Time: 1:00 p.m. to 4:00 p.m. published in the Federal Register
applications.
Agenda: To review and evaluate grant Place: National Institutes of Health during the first week of each month. If
applications. Building 31, 6th Floor, C Wing, Room 6, 31 any laboratory or IITF certification is
Place: National Institute on Aging, Center Drive, Bethesda, MD 20892. suspended or revoked, the laboratory or
Gateway Suite 2W200, 7201 Wisconsin Ave., Contact Person: Marguerite Littleton IITF will be omitted from subsequent
Bethesda, MD 20892 (Telephone Conference Kearney, Director Division of Extramural lists until such time as it is restored to
Call). Science Programs, National Institute of
Nursing Research National Institutes of
full certification under the Mandatory
Contact Person: Alexander Parsadanian,
Health, 6701 Democracy Boulevard, Room Guidelines.
Ph.D., Scientific Review Officer, National
708, Bethesda, MD 20892–4870, 301–402– If any laboratory or IITF has
Institute on Aging, Gateway Building 2C/212,
7932, marguerite.kearnet@nih.gov. withdrawn from the HHS National
7201 Wisconsin Avenue, Bethesda, MD
Any interested person may file written Laboratory Certification Program (NLCP)
20892, 301–496–9666, parsadaniana@ comments with the committee by forwarding
nia.nih.gov.
during the past month, it will be listed
the statement to the Contact Person listed on at the end and will be omitted from the
(Catalogue of Federal Domestic Assistance this notice. The statement should include the
monthly listing thereafter.
Program Nos. 93.866, Aging Research, name, address, telephone number and when
applicable, the business or professional This notice is also available on the
sradovich on DSK3GMQ082PROD with NOTICES
National Institutes of Health, HHS)
affiliation of the interested person. Internet at http://www.samhsa.gov/
Dated: November 28, 2017. In the interest of security, NIH has workplace.
Melanie J. Pantoja, instituted stringent procedures for entrance
FOR FURTHER INFORMATION CONTACT:
Program Analyst, Office of Federal Advisory onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles Giselle Hersh, Division of Workplace
Committee Policy. Programs, SAMHSA/CSAP, 5600
will be inspected before being allowed on
[FR Doc. 2017–25983 Filed 12–1–17; 8:45 am] campus. Visitors will be asked to show one Fishers Lane, Room 16N03A, Rockville,
BILLING CODE 4140–01–P form of identification (for example, a Maryland 20857; 240–276–2600 (voice).
VerDate Sep<11>2014 18:22 Dec 01, 2017 Jkt 244001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM 04DEN1](https://thefederalregister.org/doc/82_FR_57517/page/1.svg)
![57288 Federal Register / Vol. 82, No. 231 / Monday, December 4, 2017 / Notices
the HHS’ NLCP contractor continuing to with hearing or speech impairments appropriate automated collection
have an active role in the performance may access this number through TTY by techniques or other forms of information
testing and laboratory inspection calling the toll-free Federal Relay technology, e.g., permitting electronic
processes. Other Canadian laboratories Service at (800) 877–8339. submission of responses.
wishing to be considered for the NLCP Copies of available documents HUD encourages interested parties to
may apply directly to the NLCP submitted to OMB may be obtained submit comment in response to these
contractor just as U.S. laboratories do. from Ms. Guido. questions.
Upon finding a Canadian laboratory to SUPPLEMENTARY INFORMATION: This Authority: Section 3507 of the Paperwork
be qualified, HHS will recommend that notice informs the public that HUD is Reduction Act of 1995, 44 U.S.C. Chapter 35.
DOT certify the laboratory (Federal seeking approval from OMB for the Dated: November 14, 2017.
Register, July 16, 1996) as meeting the information collection described in Anna P. Guido,
minimum standards of the Mandatory Section A. Department Reports Management Officer,
Guidelines published in the Federal The Federal Register notice that Office of the Chief Information Officer.
Register on January 23, 2017 (82 FR solicited public comment on the
[FR Doc. 2017–25973 Filed 12–1–17; 8:45 am]
7920). After receiving DOT certification, information collection for a period of 60
BILLING CODE 4210–67–P
the laboratory will be included in the days was published on May 16, 2017.
monthly list of HHS-certified
A. Overview of Information Collection
laboratories and participate in the NLCP
certification maintenance program. Title of Information Collection: DEPARTMENT OF THE INTERIOR
Reporting for HUD Research,
Brian Makela, Evaluation, and Demonstration Fish and Wildlife Service
Chemist. Cooperative Agreements. [Docket No. FWS–R2–ES–2017–0036;
[FR Doc. 2017–26016 Filed 12–1–17; 8:45 am] OMB Approval Number: 2528–0299. FXES11130200000–189–FF02ENEH00]
BILLING CODE 4160–20–P Type of Request: Revision.
Form Number: No forms. Endangered and Threatened Wildlife
Description of the need for the and Plants; Final Mexican Wolf
DEPARTMENT OF HOUSING AND information and proposed use: PD&R Recovery Plan, First Revision
URBAN DEVELOPMENT intends to establish cooperative
AGENCY: Fish and Wildlife Service,
agreements with qualified for-profit and
[Docket No. FR–5997–N–75] Interior.
nonprofit research organizations and
ACTION: Notice of availability.
universities to conduct research,
30-Day Notice of Proposed Information
demonstrations, and data analysis. SUMMARY: We, the U.S. Fish and
Collection: Reporting for HUD
PD&R will issue a Notice of Funding Wildlife Service (Service), announce the
Research, Evaluation, and
Availability (NOFA) describing the availability of our Mexican Wolf
Demonstration Cooperative
cooperative research program. Recovery Plan, First Revision (Recovery
Agreements
Management of PD&R cooperative Plan). The Mexican wolf (Canis lupus
AGENCY: Office of the Chief Information agreements for research and baileyi) is listed as endangered under
Officer, HUD. demonstrations will require periodic the Endangered Species Act of 1973, as
ACTION: Notice. reporting of progress. This information amended (ESA), and is currently found
collection will be limited to recipients in the U.S. States of Arizona and New
SUMMARY: HUD submitted the proposed of cooperative agreements. Mexico, and in Chihuahua, Mexico. The
information collection requirement Respondents: HUD anticipates that recovery plan includes specific recovery
described below to the Office of approximately 8–10 organizations will criteria to be met to enable us to remove
Management and Budget (OMB) for be selected for cooperative agreement this species from the List of Endangered
review, in accordance with the award. Recipients of the cooperative and Threatened Wildlife. The first
Paperwork Reduction Act. The purpose agreements will be the sole members of Mexican wolf recovery plan was
of this notice is to allow for an the affected public for the reporting completed in 1982.
additional 30 days of public comment. requirement. ADDRESSES: You may obtain a copy of
DATES: Comments Due Date: January 3, B. Solicitation of Public Comment the recovery plan from our Web site at
2018. http://www.fws.gov/endangered/
This notice is soliciting comments
ADDRESSES: Interested persons are
from members of the public and affected species/recovery-plans.html or the
invited to submit comments regarding parties concerning the collection of Mexican Wolf Recovery Program Web
this proposal. Comments should refer to information described in Section A on site at https://www.fws.gov/southwest/
the proposal by name and/or OMB the following: es/mexicanwolf/. The recovery plan and
Control Number and should be sent to: (1) Whether the proposed collection related materials, including comments
HUD Desk Officer, Office of of information is necessary for the received on the draft recovery plan, are
Management and Budget, New proper performance of the functions of also available for public review online
Executive Office Building, Washington, the agency, including whether the at http://www.regulations.gov in Docket
DC 20503; fax: 202–395–5806. Email: information will have practical utility; No. FWS–R2–ES–2017–0036. You may
OIRA_Submission@omb.eop.gov (2) The accuracy of the agency’s also request a copy of the recovery plan
FOR FURTHER INFORMATION CONTACT: by contacting Sherry Barrett, Mexican
sradovich on DSK3GMQ082PROD with NOTICES
estimate of the burden of the proposed
Anna P. Guido, Reports Management collection of information; Wolf Recovery Coordinator, U.S. Fish
Officer, QDAM, Department of Housing (3) Ways to enhance the quality, and Wildlife Service, 2105 Osuna Road
and Urban Development, 451 7th Street, utility, and clarity of the information to NE., Albuquerque, NM 87113
SW., Washington, DC 20410; email be collected; and (telephone 505–761–4748).
Anna P. Guido at Anna.P.Guido@ (4) Ways to minimize the burden of FOR FURTHER INFORMATION CONTACT:
hud.gov or telephone 202–402–5535. the collection of information on those Sherry Barrett (see ADDRESSES).
This is not a toll-free number. Persons who are to respond; including using SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014 18:22 Dec 01, 2017 Jkt 244001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM 04DEN1](https://thefederalregister.org/doc/82_FR_57517/page/3.svg)
Document Created: 2017-12-02 00:40:01
Document Modified: 2017-12-02 00:40:01
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). | |
| FR Citation | 82 FR 57286 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR